483 John Hays Mar 2019

483 John Hays Mar 2019

Kathryn Suttling FDA$119.00 - Available Now

FDA investigators audited the John Hays - Columbus, OH, United States facility and issued inspectional observations (via FDA 483) on 22 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Mar 2019
  • Location: Columbus, United States
  • FEI: 3015092540
Add To Cart